Distraneurin
Distraneurin is a medicine authorised by Swissmedic under authorisation number 40629. The authorisation holder is Cheplapharm Schweiz GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 31 August 1978 and the authorisation is valid without a time limit. ATC code N05CM02 places the medicine in the group Psycholeptics.
| Authorisation number | 40629 |
|---|---|
| Name | Distraneurin |
| Full name | Distraneurin, Weichkapseln |
| Authorisation holder | Cheplapharm Schweiz GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | N05CM02 |
| First authorisation | 31 August 1978 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Distraneurin, Weichkapseln | A | 31 August 1978 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 17 | 25 | Kapsel(n) | N05CM02 | 01.03.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Distraneurin authorised in Switzerland?
Yes. Distraneurin is authorised by Swissmedic under authorisation number 40629, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Distraneurin have?
Distraneurin is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Distraneurin?
The authorisation holder is Cheplapharm Schweiz GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.